AN INVESTIGATION INTO FACTORS INFLUENCING REIMBURSEMENT TIMELINES OF NEW MEDICINES IN IRELAND

被引：0
|
作者：
Copeland, C. [1 ]
Dooley, B. [1 ]
Hernon, M. [1 ]
Tracey, M. [2 ]
机构：
[1] AXIS Healthcare Consulting Ltd, Dublin D, Ireland
[2] AXIS Healthcare Consulting Ltd, Dublin 2, Ireland
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PNS71
引用
收藏
页码：S655 / S655
页数：1
相关论文
共 50 条
  • [21] Comparing the reimbursement of new medicines between Australia and New Zealand
    Ragupathy, Rajan
    Babar, Zaheer-UD-Din
    [J]. AUSTRALIAN HEALTH REVIEW, 2016, 40 (01) : 118 - 119
  • [22] Exploring the implications of a fixed budget for new medicines: a study of reimbursement of new medicines in Australia and New Zealand
    Taylor, Colman
    Wonder, Michael
    [J]. AUSTRALIAN HEALTH REVIEW, 2015, 39 (04) : 455 - 461
  • [23] Challenges in Using MCDA for Reimbursement Decisions on New Medicines?
    Walker, Andrew
    [J]. VALUE IN HEALTH, 2016, 19 (02) : 123 - 124
  • [24] FACTORS INFLUENCING REIMBURSEMENT PRICE OF NEW DRUGS AFTER INTRODUCTION OF POSITIVE LIST SYSTEM
    Park, S. E.
    Yim, E. Y.
    Lim, S. H.
    Bae, S. Y.
    Lee, E. K.
    Kim, K. H.
    You, M. Y.
    Lee, B., I
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A24 - A24
  • [25] FACTORS INFLUENCING DRG 210 (FRACTURE HIP) REIMBURSEMENT
    AGARWAL, N
    REYES, JD
    WESTERMANN, DA
    CAYTEN, CG
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1985, 25 (07): : 671 - 671
  • [26] FACTORS INFLUENCING DRG 210 (HIP FRACTURE) REIMBURSEMENT
    AGARWAL, N
    REYES, JD
    WESTERMAN, DA
    CAYTEN, CG
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1986, 26 (05): : 426 - 431
  • [27] FACTORS AFFECTING TIME TO REIMBURSEMENT OF NOVEL ANTICANCER DRUGS IN IRELAND
    Henderson, R.
    Redmond, S.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S335 - S335
  • [28] Waiting for Reimbursement of New Medicines in CanadaIt’s Time for a Rethink
    Brett J. Skinner
    [J]. PharmacoEconomics, 2008, 26 : 629 - 632
  • [29] Factors influencing pharmaceutical industry-affiliated clinical trial publication timelines
    Banner, Steve
    Rees, Tomas
    Liew, Andrew
    Brown, Nick
    Dhanky, Vini
    Humphreys, Luke
    Naimy, Hicham
    Peters, David H.
    Young, Fran
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 : S21 - S21
  • [30] Author reply: exploring the implications of a fixed budget for new medicines: a study of reimbursement of new medicines in Australia and New Zealand
    Taylor, Colman B.
    Wonder, Michael
    [J]. AUSTRALIAN HEALTH REVIEW, 2016, 40 (01) : 120 - 120
12345